Singapore Health Sciences Authority (HSA) had implemented the first phase voluntary notification initiative for Health Supplements and Traditional Medicines on 1st August 2022.
Previous related article can be found at the following link: https://www.pharmatomarket.com/singapore-hsa-releases-guideline-on-voluntary-notification-system-for-health-supplements-and-traditional-medicines/?utm_source=rss&utm_medium=rss&utm_campaign=singapore-hsa-releases-guideline-on-voluntary-notification-system-for-health-supplements-and-traditional-medicines
During the first phase of the voluntary notification, HSA’s initiative focus on commonly purchased products such as vitamin and mineral supplements, and products at higher risk of adulteration such as those for weight loss, pain relief and male vitality enhancement. Since its launch, HSA has received positive participation. HSA is pleased to announce that the second phase of this initiative will commence on 1 August 2023. It will include the following product types:
– Other health supplements and traditional medicines (e.g. probiotics, omega fatty acids,
glucosamine, Echinacea supplements, herbal cough, cold and flu medicines, tonics, etc.)
– Medicated oils, balms and medicated plasters
Similarly, companies that participate in this initiative are required to provide HSA with the relevant documents to demonstrate that their products meet the necessary safety and quality standards and labelling requirements. Only products that are compliant with these standards will be published on the HSA database. For more information on the submission procedure and requirements of the voluntary notification, please refer to HSA’s website at the following link: https://www.hsa.gov.sg/health-supplements/vns